<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-124126" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Vitamin B5 (Pantothenic Acid)</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sanvictores</surname>
            <given-names>Terrence</given-names>
          </name>
          <aff>Touro University, Nevada</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chauhan</surname>
            <given-names>Shaylika</given-names>
          </name>
          <aff>Geisinger Health System</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Terrence Sanvictores declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shaylika Chauhan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>29</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-124126.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p content-type="pubmed-excerpt">Vitamin B5, also known as pantothenic acid, is a water-soluble nutrient necessary for various metabolic functions within the body. This essential vitamin participates in energy generation, synthesizing hormones, and maintaining optimal conditions for skin, hair, and nails. Supplemental vitamin B5 is employed to address and mitigate nutrient deficiencies. This activity&#x000a0;discusses the mechanisms of action, adverse event profile, off-label applications, appropriate dosing strategies, pharmacodynamics, pharmacokinetics, monitoring procedures, and relevant interactions of vitamin B5.&#x000a0;Participants gain insights and knowledge essential for managing cases involving nutritional deficiencies and related conditions.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify sources of vitamin B5 (pantothenic acid) in various food sources and dietary supplements.</p></list-item><list-item><p>Screen patients for potential vitamin B5 deficiency based on their medical history, symptoms, and laboratory tests.</p></list-item><list-item><p>Implement appropriate strategies for vitamin B5 supplementation in patients with confirmed deficiency or inadequate intake.</p></list-item><list-item><p>Develop communication with patients about&#x000a0;the importance of adequate vitamin B5 intake and incorporating food sources rich in this vitamin into their diet.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=124126&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=124126">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-124126.s2" sec-type="Indications">
        <title>Indications</title>
        <p>Vitamin B5 (pantothenic acid) is a naturally occurring substance in various plants and animals (ie, eggs, milk, vegetables, beef, chicken, and whole grains). Vitamin B5 is also supplementally added to foods. Deficiency of this vitamin is rare but can present in people with severe malnutrition. A patient with vitamin B5 deficiency commonly has deficiencies in other nutrients, making it challenging to identify vitamin B5 deficiency specifically. An experimental vitamin B5 deficiency study associated the deficiency with symptoms such as fatigue, headache, malaise, personality changes, numbness, muscle cramps, paresthesia, muscle/abdominal cramps, nausea, and impaired muscle coordination.<xref ref-type="bibr" rid="article-124126.r1">[1]</xref></p>
        <p>
<bold>Discovery and Isolation</bold>
</p>
        <p>American biochemist Roger J. Williams isolated pantothenic acid as a growth factor in 1931. He derived its name from the Greek word "pantos," meaning "everywhere," as small quantities of pantothenic acid are found in nearly every food. Williams et al noted that a single acid substance could stimulate the growth of <italic toggle="yes">Saccharomyces&#x000a0;cerevisiae</italic>&#x000a0;and that this substance was a 'universal constituent of living matter.'&#x000a0;</p>
        <p>The molecule's chemical structure was determined by Williams in 1940. Elvehjem et al and Jukes et al demonstrated that pantothenic acid was a growth and "anti-dermatitis" factor for chickens. In the 1950s, one of the functional forms of pantothenic acid, coenzyme A (CoA), was discovered as the cofactor essential for the acetylation of sulfonamides and choline. In the mid-1960s, pantothenic acid was identified as a component of an acyl carrier protein (ACP) in the fatty acid synthesis complex. Fritz Albert Lipmann won the Nobel Prize in Physiology and Medicine "for his discovery of coenzyme A and its importance for intermediary metabolism."<xref ref-type="bibr" rid="article-124126.r2">[2]</xref> All genomes sequenced to date encode enzymes that use coenzyme A as a substrate, the biosynthesis of which requires cysteine, pantothenate (vitamin B5), and adenosine triphosphate (ATP).<xref ref-type="bibr" rid="article-124126.r3">[3]</xref></p>
        <p>
<bold>FDA Approval</bold>
</p>
        <p>Vitamin B5 (pantothenic acid) supplements are not subject to initial review by the U.S. Food and Drug Administration (FDA). The agency does not have the authority to examine dietary supplement products for safety and effectiveness before marketing. Out of all the drugs listed in this indications section, only panthenol and dexpanthenol are approved by the FDA for use in cosmetics. All other indications listed are non-FDA approved.</p>
        <p>
<bold>Indications</bold>
</p>
        <p>The usage of vitamin B5 is prevalent within the field of dermatology.<xref ref-type="bibr" rid="article-124126.r4">[4]</xref>&#x000a0;This interest has led to a study that compares the effectiveness of dexpanthenol (an alcoholic analog of D-pantothenic acid) as an alternative treatment to atopic dermatitis against a standard treatment of hydrocortisone. The study found that dexpanthenol can potentially treat mild to moderate childhood atopic dermatitis therapy.<xref ref-type="bibr" rid="article-124126.r5">[5]</xref>&#x000a0;</p>
        <p>Other research suggests that dexpanthenol cream can help manage mucocutaneous side effects during isotretinoin therapy.<xref ref-type="bibr" rid="article-124126.r6">[6]</xref>&#x000a0;Isotretinoin therapy is used for acne treatment, and its mucocutaneous side effects include dry mucous membranes, cheilitis, and xerosis.&#x000a0;</p>
        <p>Clinical studies have been conducted on dexpanthenol in wound healing applications. These small clinical trials used the drug as a pastille or spray to heal wounds in postoperative endotracheal intubation, endoscopic sinus surgery, and tonsillectomy.<xref ref-type="bibr" rid="article-124126.r7">[7]</xref><xref ref-type="bibr" rid="article-124126.r8">[8]</xref><xref ref-type="bibr" rid="article-124126.r9">[9]</xref>&#x000a0;The use&#x000a0;of dexpanthenol shows better clinical outcomes in these clinical trials. Regardless, further studies are necessary to&#x000a0;determine drug efficacy.&#x000a0;</p>
        <p>Dyslipidemia is another field that can potentially&#x000a0;benefit from vitamin B5 use. Since vitamin B5 is essential for the biosynthesis of coenzyme A, it plays a role in the metabolism of lipids. One study concluded that pantethine (a derivative of vitamin B5) lowered cardiovascular disease risk markers in low to moderate-risk participants.<xref ref-type="bibr" rid="article-124126.r10">[10]</xref>&#x000a0;These risk markers include LDL, HDL, and total cholesterol.&#x000a0;</p>
        <p>Pantothenate deficiency can play a vital role in acetylcholine deficiency, neurodegeneration, myelin loss, and age-related dementias like Huntington disease.<xref ref-type="bibr" rid="article-124126.r11">[11]</xref>&#x000a0;Nevertheless, more studies are still needed to test the clinical efficacy of vitamin B5 in these conditions.</p>
        <p>
<bold>Off-Label Uses</bold>
</p>
        <p>Individuals with a pantothenate kinase 2 (PANK2) gene mutation are also likely to have a pantothenic acid inadequacy. PANK2 mutations can reduce the activity of pantothenate kinase 2, potentially decreasing the conversion of pantothenic acid to coenzyme A (CoA) and reducing CoA levels. PANK2 gene mutations also cause pantothenate kinase-associated neurodegeneration (PKAN). A common hallmark of individuals with PKAN is an iron accumulation in the brain, forming a pattern called the "eye of the tiger" sign.<xref ref-type="bibr" rid="article-124126.r12">[12]</xref>&#x000a0;</p>
        <p>PKAN&#x000a0;also presents with a progressive movement disorder; other symptoms may vary significantly from case to case. Symptoms include dysarthria, dystonia, poor balance, spasticity, and muscle rigidity. Treatment of this condition focuses mainly on reducing symptoms. A few anecdotal reports indicate that vitamin B5 supplements can reduce symptoms, but the benefits of this supplement's general use in PKAN are unknown.<xref ref-type="bibr" rid="article-124126.r13">[13]</xref></p>
      </sec>
      <sec id="article-124126.s3" sec-type="Mechanism of Action">
        <title>Mechanism of Action</title>
        <p>Vitamin B5 is exclusively a precursor in coenzyme A (CoA) synthesis and thus only directly affects this metabolic pathway. CoA has a role in hundreds of human biochemical reactions, such as cell growth, intermediary metabolism, and neurotransmitter synthesis.<xref ref-type="bibr" rid="article-124126.r14">[14]</xref><xref ref-type="bibr" rid="article-124126.r15">[15]</xref>&#x000a0;The structure of CoA functions as a carbonyl-activating group and as an acyl group carrier to help facilitate these various reactions.<xref ref-type="bibr" rid="article-124126.r16">[16]</xref></p>
        <p>
<bold>Pharmacokinetics</bold>
</p>
        <p>Pantothenic acid is commonly found in the form of CoASH or peptide-bound 4&#x02032;-phosphopantetheine.</p>
        <p><bold>Absorption:&#x000a0;</bold>To be absorbed into the body, these substances must undergo hydrolysis by intestinal enzymes. This process occurs through the sequential action of&#x000a0;2 intestinal hydrolases: a pyrophosphatase and a phosphatase. Pantetheine, the resulting product, can then be metabolized into pantothenic acid with the help of another intestinal hydrolase called pantetheinase.</p>
        <p>When proteins and peptides, such as those derived from ACP, are hydrolyzed, there is an almost complete release of pantothenic acid or pantetheine. Following the enzymatic release, the absorption of pantothenic acid or pantetheine takes place through a sodium-dependent multivitamin transporter, with a Km (Michaelis constant) value of 10&#x000a0;to 20 &#x003bc;M for pantothenic acid uptake in the intestines.<xref ref-type="bibr" rid="article-124126.r17">[17]</xref></p>
        <p><bold>Distribution:&#x000a0;</bold>The absorption of free pantothenic acid occurs within intestinal cells through a saturable, sodium-dependent active transport system. When pantothenic acid intake is high, and the transport system reaches its maximum capacity, a portion of it may also be absorbed through passive diffusion. Consequently, when the intake of pantothenic acid increases by a factor of 10, the rate of absorption decreases to 10%.<xref ref-type="bibr" rid="article-124126.r17">[17]</xref></p>
        <p><bold>Metabolism:&#x000a0;</bold>The synthesis of CoA from pantothenate is regulated primarily by pantothenate kinase, an enzyme inhibited by the pathway end products CoA and acyl CoA.<xref ref-type="bibr" rid="article-124126.r18">[18]</xref></p>
        <p><bold>Elimination:&#x000a0;</bold>Pantothenic acid is excreted intact in urine, and the amount excreted varies proportionally with dietary intake.<xref ref-type="bibr" rid="article-124126.r18">[18]</xref></p>
      </sec>
      <sec id="article-124126.s4" sec-type="Administration">
        <title>Administration</title>
        <p><bold>Available Dosage Forms</bold>&#x000a0;</p>
        <p>Dietary supplements of vitamin B5 are available as vitamin B5 exclusively or in combination with other vitamins in multivitamin/multimineral products. Patients typically&#x000a0;take these supplements orally. Depending on the application, derivatives of vitamin B5 can be applied topically and even through injection using IV formulas. Dexpanthenol administration can be administered via an oral spray in the mouth.<xref ref-type="bibr" rid="article-124126.r9">[9]</xref></p>
        <p><bold>Available Strengths</bold>&#x000a0;</p>
        <p>Dietary supplements commonly contain varying amounts of pantothenic acid. The quantity typically varies between approximately 10 mg in multivitamin/multimineral products and can go up to 1,000 mg in supplements that specifically target B-complex vitamins or solely pantothenic acid.</p>
        <p>
<bold>Adult Dosage</bold>
</p>
        <p>Adults should take 5 mg/d.<xref ref-type="bibr" rid="article-124126.r19">[19]</xref>&#x000a0;Pregnant women should take 6 mg/d, and lactating women should take 7 mg/d. If administered orally, take it with food.&#x000a0;</p>
        <p>
<bold>Use in Hyperlipidemia</bold>
</p>
        <p>In patients with low to moderate cardiovascular risk, with a therapeutic lifestyle and change of diet enriched with pantethine during 16 weeks (600 mg/d from weeks 1&#x000a0;to 8 and 900 mg/d from weeks 9&#x000a0;to 16), a significant decrease in total cholesterol at 16 weeks and LDL cholesterol in 8&#x000a0;to 16 weeks compared to placebo was observed. The decreasing trend was also evident in non-high-density-lipoprotein cholesterol at weeks 8 and 12, which reached significance at 16 weeks. The level of CoQ10 significantly increased above the baseline in both groups, and homocysteine levels did not change.<xref ref-type="bibr" rid="article-124126.r10">[10]</xref></p>
        <p>
<bold>Pediatric Dosage</bold>
</p>
        <table-wrap id="article-124126.table0" position="float" orientation="portrait">
          <table style="width: 400px;" border="1" cellspacing="1" cellpadding="2">
            <tbody>
              <tr style="height: 13px;">
                <td style="width: 106.867px; height: 13px;" rowspan="1" colspan="1">Age</td>
                <td style="width: 132.133px; height: 13px;" rowspan="1" colspan="1">Daily Dosage (mg)</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 106.867px; height: 13px;" rowspan="1" colspan="1">&#x0003c;6 months</td>
                <td style="width: 132.133px; height: 13px;" rowspan="1" colspan="1">1.7</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 106.867px; height: 13px;" rowspan="1" colspan="1">7 to 12 months</td>
                <td style="width: 132.133px; height: 13px;" rowspan="1" colspan="1">1.8</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 106.867px; height: 13px;" rowspan="1" colspan="1">1 to 3</td>
                <td style="width: 132.133px; height: 13px;" rowspan="1" colspan="1">2</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 106.867px; height: 13px;" rowspan="1" colspan="1">4 to 8</td>
                <td style="width: 132.133px; height: 13px;" rowspan="1" colspan="1">3</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 106.867px; height: 13px;" rowspan="1" colspan="1">9 to 13</td>
                <td style="width: 132.133px; height: 13px;" rowspan="1" colspan="1">4</td>
              </tr>
              <tr>
                <td style="width: 106.867px;" rowspan="1" colspan="1">14 to 18</td>
                <td style="width: 132.133px;" rowspan="1" colspan="1">5</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>
<bold>Specific Patient Population</bold>
</p>
        <p><bold>Hepatic impairment: </bold>There are no adjustments provided in the manufacturer's labeling for liver disease.</p>
        <p><bold>Renal impairment:&#x000a0;</bold>There are no adjustments provided in the manufacturer's labeling for kidney disease.</p>
        <p>The following foods contain pantothenic acid&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Beef, poultry,&#x000a0;seafood, and organ meats</p>
          </list-item>
          <list-item>
            <p>Eggs and milk</p>
          </list-item>
          <list-item>
            <p>Vegetables such as mushrooms (especially shiitakes), avocados, potatoes, and broccoli</p>
          </list-item>
          <list-item>
            <p>Whole grains, such as whole wheat, brown rice, and oats</p>
          </list-item>
          <list-item>
            <p>Peanuts, sunflower seeds, and chickpeas&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Orphan Drug Use</bold>
</p>
        <p>Pantothenate kinase-associated neurodegeneration (PKAN), is an uncommon hereditary movement disorder affecting the central nervous system and includes a cluster of clinical conditions featuring progressive involuntary movements, changes in muscle tone, and disruptions in posture (extrapyramidal symptoms).</p>
        <p>PKAN is a hereditary condition characterized by mutations in the PANK2 gene on chromosome 20, resulting in an autosomal recessive inheritance pattern. The PANK2 gene produces the enzyme pantothenate kinase, essential for metabolizing vitamin B5 (pantothenate). These gene mutations disrupt the normal metabolism of vitamin B5, which is crucial for synthesizing coenzyme A within cells. Consequently, the impairment of this enzyme profoundly impacts energy and lipid metabolism, potentially causing the accumulation of detrimental substances in the brain, including iron. Currently, PANK2 stands as the sole identified gene associated with PKAN.<xref ref-type="bibr" rid="article-124126.r20">[20]</xref>&#x000a0;</p>
        <p>The association between pantothenate kinase and PKAN suggests that supplemental pantothenate (eg, pantothenic acid, calcium pantothenate) taken orally could be beneficial; further clinical trials are needed to study this association.</p>
      </sec>
      <sec id="article-124126.s5" sec-type="Adverse Effects">
        <title>Adverse Effects</title>
        <p>As previously stated, vitamin B5 is considered generally safe.<xref ref-type="bibr" rid="article-124126.r21">[21]</xref>&#x000a0;There are no established upper limits since there have been no reports of vitamin B5 toxicity in humans with high intakes. However, there are still side effects involved with the administration of this drug, which include the following.</p>
        <p>
<bold>Common Adverse Effects</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Muscle pain</p>
          </list-item>
          <list-item>
            <p>Joint pain</p>
          </list-item>
          <list-item>
            <p>Diabetes mellitus, new-onset</p>
          </list-item>
          <list-item>
            <p>Sore throat</p>
          </list-item>
          <list-item>
            <p>Headache</p>
          </list-item>
          <list-item>
            <p>Weakness/lack of energy</p>
          </list-item>
          <list-item>
            <p>Dizziness&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Creatine phosphokinase (CPK) elevation</p>
          </list-item>
          <list-item>
            <p>Nausea&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Abdominal pain</p>
          </list-item>
          <list-item>
            <p>Alanine transaminase (ALT)&#x000a0;elevation</p>
          </list-item>
          <list-item>
            <p>Constipation&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Flulike illness</p>
          </list-item>
          <list-item>
            <p>Urinary tract infection (UTI)&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Hypersensitivity reactions (including rash, itching, hives, and swelling)</p>
          </list-item>
          <list-item>
            <p>Pancreatitis</p>
          </list-item>
        </list>
        <p>
<bold>Less Common&#x000a0;Adverse&#x000a0;Effects</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Yellowing skin and eyes (jaundice)</p>
          </list-item>
          <list-item>
            <p>Muscle disease</p>
          </list-item>
          <list-item>
            <p>Muscle wasting (rhabdomyolysis)</p>
          </list-item>
        </list>
        <p>Vitamin B5 doses are age-dependent and if the patient is pregnant or lactating. Doses greater than 10 g/d may cause mild diarrhea or mild intestinal distress.<xref ref-type="bibr" rid="article-124126.r21">[21]</xref>&#x000a0;Cases of allergic contact dermatitis with the topical use of panthenol cream and dexpanthenol have been reported.<xref ref-type="bibr" rid="article-124126.r22">[22]</xref><xref ref-type="bibr" rid="article-124126.r23">[23]</xref></p>
      </sec>
      <sec id="article-124126.s6" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>
<bold>Drug-Drug Interactions</bold>
</p>
        <p>The following drugs have moderate interactions with vitamin B5:</p>
        <list list-type="bullet">
          <list-item>
            <p>Azithromycin</p>
          </list-item>
          <list-item>
            <p>Clarithromycin</p>
          </list-item>
          <list-item>
            <p>Erythromycin base</p>
          </list-item>
          <list-item>
            <p>Erythromycin ethyl succinate</p>
          </list-item>
          <list-item>
            <p>Erythromycin lactobionate</p>
          </list-item>
          <list-item>
            <p>Erythromycin stearate</p>
          </list-item>
          <list-item>
            <p>Roxithromycin</p>
          </list-item>
        </list>
        <p>
<bold>Warnings and Precautions</bold>
</p>
        <p>Patients should&#x000a0;not take vitamin B5 if they are allergic to pantothenic acid or any ingredients contained in the formulation.</p>
        <p>At least 60 other drugs have mild interactions with vitamin B5. Other contraindications include patients with hypersensitivity or allergy to the drug or its derivatives. A report suggests that vitamin B5 intake might correlate with increased cerebral amyloid-beta peptide burden in individuals with cognitive impairment. Although further studies are still needed to confirm the findings and discover the molecular mechanisms of this pathway, the current research suggests those with cognitive impairment to be a potential contraindication.<xref ref-type="bibr" rid="article-124126.r24">[24]</xref></p>
      </sec>
      <sec id="article-124126.s7" sec-type="Monitoring">
        <title>Monitoring</title>
        <p>Vitamin B5 is considered relatively safe. Dosages above the recommended amount can induce mild diarrhea&#x000a0;or intestinal distress. Allergic reactions and hypersensitivity can also occur with its derivatives.</p>
      </sec>
      <sec id="article-124126.s8" sec-type="Toxicity">
        <title>Toxicity</title>
        <p>Toxicity is likely at&#x000a0;10,000 mg daily and causes upset stomach and diarrhea as the most common symptoms, according to the&#x000a0;National Institutes of Health (NIH) Office of Dietary Supplements.<xref ref-type="bibr" rid="article-124126.r18">[18]</xref></p>
      </sec>
      <sec id="article-124126.s9" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Vitamin B5 levels can be determined through blood or urine tests. Properly evaluating and classifying nutrient deficiencies leads to improved patient healthcare outcomes. Cohesiveness and open communication among a patient&#x02019;s interprofessional healthcare team members allow optimal therapy and necessary interventions.&#x000a0;</p>
      </sec>
      <sec id="article-124126.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=124126&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=124126">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/124126/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=124126">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-124126.s11">
        <title>References</title>
        <ref id="article-124126.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>HODGES</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>OHLSON</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>BEAN</surname>
                <given-names>WB</given-names>
              </name>
            </person-group>
            <article-title>Pantothenic acid deficiency in man.</article-title>
            <source>J Clin Invest</source>
            <year>1958</year>
            <month>Nov</month>
            <volume>37</volume>
            <issue>11</issue>
            <fpage>1642</fpage>
            <page-range>1642-57</page-range>
            <pub-id pub-id-type="pmid">13587673</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124126.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shampo</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Kyle</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Fritz Lipmann--Nobel Prize in discovery of coenzyme A.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2000</year>
            <month>Jan</month>
            <volume>75</volume>
            <issue>1</issue>
            <fpage>30</fpage>
            <pub-id pub-id-type="pmid">10630754</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124126.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Daugherty</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Polanuyer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Farrell</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Scholle</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lykidis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>de Cr&#x000e9;cy-Lagard</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Osterman</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Complete reconstitution of the human coenzyme A biosynthetic pathway via comparative genomics.</article-title>
            <source>J Biol Chem</source>
            <year>2002</year>
            <month>Jun</month>
            <day>14</day>
            <volume>277</volume>
            <issue>24</issue>
            <fpage>21431</fpage>
            <page-range>21431-9</page-range>
            <pub-id pub-id-type="pmid">11923312</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124126.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gunaydin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bilge</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Effects of Nonsteroidal Anti-Inflammatory Drugs at the Molecular Level.</article-title>
            <source>Eurasian J Med</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>50</volume>
            <issue>2</issue>
            <fpage>116</fpage>
            <page-range>116-121</page-range>
            <pub-id pub-id-type="pmid">30002579</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124126.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Udompataikul</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Limpa-o-vart</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Comparative trial of 5% dexpanthenol in water-in-oil formulation with 1% hydrocortisone ointment in the treatment of childhood atopic dermatitis: a pilot study.</article-title>
            <source>J Drugs Dermatol</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>366</fpage>
            <page-range>366-74</page-range>
            <pub-id pub-id-type="pmid">22395588</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124126.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Romiti</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Romiti</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Dexpanthenol cream significantly improves mucocutaneous side effects associated with isotretinoin therapy.</article-title>
            <source>Pediatr Dermatol</source>
            <year>2002</year>
            <season>Jul-Aug</season>
            <volume>19</volume>
            <issue>4</issue>
            <fpage>368</fpage>
            <pub-id pub-id-type="pmid">12220290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124126.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gulhas</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Canpolat</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cicek</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yologlu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Togal</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Durmus</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ozcan Ersoy</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Dexpanthenol pastille and benzydamine hydrochloride spray for the prevention of post-operative sore throat.</article-title>
            <source>Acta Anaesthesiol Scand</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>51</volume>
            <issue>2</issue>
            <fpage>239</fpage>
            <page-range>239-43</page-range>
            <pub-id pub-id-type="pmid">17073853</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124126.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tantilipikorn</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tunsuriyawong</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jareoncharsri</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bedavanija</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Assanasen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bunnag</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Metheetrairut</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>A randomized, prospective, double-blind study of the efficacy of dexpanthenol nasal spray on the postoperative treatment of patients with chronic rhinosinusitis after endoscopic sinus surgery.</article-title>
            <source>J Med Assoc Thai</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>95</volume>
            <issue>1</issue>
            <fpage>58</fpage>
            <page-range>58-63</page-range>
            <pub-id pub-id-type="pmid">22379743</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124126.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Celebi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tepe</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Yelken</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Celik</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Efficacy of dexpanthenol for pediatric post-tonsillectomy pain and wound healing.</article-title>
            <source>Ann Otol Rhinol Laryngol</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>122</volume>
            <issue>7</issue>
            <fpage>464</fpage>
            <page-range>464-7</page-range>
            <pub-id pub-id-type="pmid">23951700</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124126.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Evans</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rumberger</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Azumano</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Napolitano</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Citrolo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kamiya</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Pantethine, a derivative of vitamin B5, favorably alters total, LDL and non-HDL cholesterol in low to moderate cardiovascular risk subjects eligible for statin therapy: a triple-blinded placebo and diet-controlled investigation.</article-title>
            <source>Vasc Health Risk Manag</source>
            <year>2014</year>
            <volume>10</volume>
            <fpage>89</fpage>
            <page-range>89-100</page-range>
            <pub-id pub-id-type="pmid">24600231</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124126.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ismail</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kureishy</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Church</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Scholefield</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Unwin</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Patassini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>GJS</given-names>
              </name>
            </person-group>
            <article-title>Vitamin B5 (d-pantothenic acid) localizes in myelinated structures of the rat brain: Potential role for cerebral vitamin B5 stores in local myelin homeostasis.</article-title>
            <source>Biochem Biophys Res Commun</source>
            <year>2020</year>
            <month>Jan</month>
            <day>29</day>
            <volume>522</volume>
            <issue>1</issue>
            <fpage>220</fpage>
            <page-range>220-225</page-range>
            <pub-id pub-id-type="pmid">31759626</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124126.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dezfouli</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Jaberi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Alavi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rezvani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shahidi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Elahi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rohani</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pantothenate kinase 2 mutation with eye-of-the-tiger sign on magnetic resonance imaging in three siblings.</article-title>
            <source>Iran J Neurol</source>
            <year>2012</year>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>155</fpage>
            <page-range>155-8</page-range>
            <pub-id pub-id-type="pmid">24250886</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124126.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kurian</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Hayflick</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Pantothenate kinase-associated neurodegeneration (PKAN) and PLA2G6-associated neurodegeneration (PLAN): review of two major neurodegeneration with brain iron accumulation (NBIA) phenotypes.</article-title>
            <source>Int Rev Neurobiol</source>
            <year>2013</year>
            <volume>110</volume>
            <fpage>49</fpage>
            <page-range>49-71</page-range>
            <pub-id pub-id-type="pmid">24209433</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124126.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leonardi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jackowski</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Biosynthesis of Pantothenic Acid and Coenzyme A.</article-title>
            <source>EcoSal Plus</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>2</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">26443589</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124126.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayflick</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Defective pantothenate metabolism and neurodegeneration.</article-title>
            <source>Biochem Soc Trans</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>42</volume>
            <issue>4</issue>
            <fpage>1063</fpage>
            <page-range>1063-8</page-range>
            <pub-id pub-id-type="pmid">25110003</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124126.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davaapil</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tsuchiya</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Gout</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Signalling functions of coenzyme A and its derivatives in mammalian cells.</article-title>
            <source>Biochem Soc Trans</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>42</volume>
            <issue>4</issue>
            <fpage>1056</fpage>
            <page-range>1056-62</page-range>
            <pub-id pub-id-type="pmid">25110002</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124126.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>BROWN</surname>
                <given-names>GM</given-names>
              </name>
            </person-group>
            <article-title>Assay and distribution of bound forms of pantothenic acid.</article-title>
            <source>J Biol Chem</source>
            <year>1959</year>
            <month>Feb</month>
            <volume>234</volume>
            <issue>2</issue>
            <fpage>379</fpage>
            <page-range>379-82</page-range>
            <pub-id pub-id-type="pmid">13630914</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124126.r18">
          <label>18</label>
          <element-citation publication-type="book">
            <collab>Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline</collab>
            <source>Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B<sub>6</sub>, Folate, Vitamin B<sub>12</sub>, Pantothenic Acid, Biotin, and Choline</source>
            <publisher-name>National Academies Press (US)</publisher-name>
            <publisher-loc>Washington (DC)</publisher-loc>
            <year>1998</year>
            <pub-id pub-id-type="pmid">23193625</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124126.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tahiliani</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Beinlich</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Pantothenic acid in health and disease.</article-title>
            <source>Vitam Horm</source>
            <year>1991</year>
            <volume>46</volume>
            <fpage>165</fpage>
            <page-range>165-228</page-range>
            <pub-id pub-id-type="pmid">1746161</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124126.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leoni</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Strittmatter</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zorzi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zibordi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dusi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Garavaglia</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Venco</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Caccia</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Souza</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Deik</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Clish</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Rimoldi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ciusani</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bertini</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nardocci</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mootha</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Tiranti</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Metabolic consequences of mitochondrial coenzyme A deficiency in patients with PANK2 mutations.</article-title>
            <source>Mol Genet Metab</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>105</volume>
            <issue>3</issue>
            <fpage>463</fpage>
            <page-range>463-71</page-range>
            <pub-id pub-id-type="pmid">22221393</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124126.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chawla</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kvarnberg</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Hydrosoluble vitamins.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2014</year>
            <volume>120</volume>
            <fpage>891</fpage>
            <page-range>891-914</page-range>
            <pub-id pub-id-type="pmid">24365359</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124126.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bregnbak</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Johansen</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Zachariae</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Contact dermatitis caused by panthenol used for aftercare treatment of a new tattoo.</article-title>
            <source>Contact Dermatitis</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>75</volume>
            <issue>1</issue>
            <fpage>50</fpage>
            <page-range>50-2</page-range>
            <pub-id pub-id-type="pmid">27264289</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124126.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chin</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>NM</given-names>
              </name>
            </person-group>
            <article-title>Allergic contact dermatitis caused by panthenol in a child.</article-title>
            <source>Contact Dermatitis</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>69</volume>
            <issue>5</issue>
            <fpage>321</fpage>
            <page-range>321-2</page-range>
            <pub-id pub-id-type="pmid">24117747</pub-id>
          </element-citation>
        </ref>
        <ref id="article-124126.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Ahn</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Won</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HW</given-names>
              </name>
            </person-group>
            <article-title>Dietary intake of pantothenic acid is associated with cerebral amyloid burden in patients with cognitive impairment.</article-title>
            <source>Food Nutr Res</source>
            <year>2018</year>
            <volume>62</volume>
            <pub-id pub-id-type="pmid">30574044</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
